Table 1.
Clinical Characteristics and Sociodemographic of the Study Population
| Characteristic | No. of Patients (n = 282) |
|---|---|
| Gender | |
| Male | 135 (47.9%) |
| Female | 147 (52.1%) |
| Age at study entry (years) | |
| Median | 60 |
| Range | 26–81 |
| ECOG performance status | |
| 0 | 273 (96.8%) |
| 1 | 9 (3.2%) |
| Primary tumor site | |
| Colonic | 147 (52.1%) |
| Rectal | 109 (38.7%) |
| Others | 26 (9.2%) |
| Clinical stage | |
| Stage II | 31 (11.0%) |
| Stage IIIa | 141 (50.0%) |
| Stage IIIb | 81 (28.7%) |
| Stage IV | 29 (10.3%) |
| Living status | |
| Living with family | 254 (90.1%) |
| Living alone | 28 (9.9%) |
| Duration of use (cycle) | |
| Mean (SD) | 7.28 (1.84) |
| Range | 1–8 |
| Total treatment number | 2,055 |
ECOG, Eastern Cooperative Oncology Group.